Researcher.Life Logo

Journal of Experimental Therapeutics and Oncology : Impact Factor & More

eISSN: 1533-869XpISSN: 1359-4117

Key Metrics

CiteScore
1.4
H-Index
39
SJR
Q4Pharmacology
SNIP
0.39
Recommended pre-submission checks
Powered by Paperpal by Editage

Journal of Experimental Therapeutics and Oncology Journal Specifications

Indexed in the following public directories

  • SJR SJR
Overview
Publisher OLD CITY PUBLISHING INC
Language English
Frequency Semi-annual
General Details
LanguageEnglish
FrequencySemi-annual
Publication Start Year1996
Publisher URLVisit website
Website URLVisit website
View less

Looking for the right journals to submit your mansucript?

Upload your manuscript and get a submission readiness score and other journal recommendations.

Check my Paper

Recently Published Papers in Journal of Experimental Therapeutics and Oncology

Phase II study of bevacizumab, cisplatin, and pemetrexed in advanced non-squamous non-small cell lung cancer (NS-NSCLC) with EGFR wild-type.
  • 1 Dec 2019
  • Journal of experimental therapeutics & oncology
Clear cell variant of Oral Squamous cell carcinoma.
  • 1 Dec 2019
  • Journal of experimental therapeutics & oncology
Effectiveness of structured teaching programme on knowledge and practice regarding care of children with leukemia among mothers.
  • 1 Dec 2019
  • Journal of experimental therapeutics & oncology
Glandular odontogenic cyst: a case report in an asymptomatic patient.
  • 1 Dec 2019
  • Journal of experimental therapeutics & oncology
Could there be any role of thiol disulphide homeostasis and ischemia modified albumin in the pathogenesis of endometrial polyps?
  • 1 Dec 2019
  • Journal of experimental therapeutics & oncology
Mebendazole in simultaneous combination with dexamethasone-(C21-phosphoramidate)-[anti-EGFR] generated utilizing a novel synthesis regimen: dual anti-neoplastic cytotoxicity against pulmonary adenocarcinoma (A549).
  • 1 Dec 2019
  • Journal of experimental therapeutics & oncology
Phase II study of bevacizumab, cisplatin, and pemetrexed in advanced non-squamous non-small cell lung cancer (NS-NSCLC) with EGFR wild-type.
  • 1 Dec 2019
  • Journal of experimental therapeutics & oncology
Clear cell variant of Oral Squamous cell carcinoma.
  • 1 Dec 2019
  • Journal of experimental therapeutics & oncology
Effectiveness of structured teaching programme on knowledge and practice regarding care of children with leukemia among mothers.
  • 1 Dec 2019
  • Journal of experimental therapeutics & oncology
Glandular odontogenic cyst: a case report in an asymptomatic patient.
  • 1 Dec 2019
  • Journal of experimental therapeutics & oncology
Could there be any role of thiol disulphide homeostasis and ischemia modified albumin in the pathogenesis of endometrial polyps?
  • 1 Dec 2019
  • Journal of experimental therapeutics & oncology
Mebendazole in simultaneous combination with dexamethasone-(C21-phosphoramidate)-[anti-EGFR] generated utilizing a novel synthesis regimen: dual anti-neoplastic cytotoxicity against pulmonary adenocarcinoma (A549).
  • 1 Dec 2019
  • Journal of experimental therapeutics & oncology

FAQs on Journal of Experimental Therapeutics and Oncology